Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular versus intravenous ketamine + midazolam + atropine sedation for pediatric dental treatment
IRCT20180401039166N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine, midazolam and atropine in Procedural anxiety (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Amount of sedation, Behavioral evaluation based on the Houpt criterion and 2 more. Started Jan 2025; status: completed.
02
Drugs
ketaminemidazolamatropine
03
Conditions
Procedural anxiety
Beyond the preview
Go deeper on IRCT20180401039166N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180401039166N1.